• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HORMONAL MARKERS IN THE STUDY OF PITUITARY ADENOMAS.垂体腺瘤研究中的激素标志物
Med J Armed Forces India. 1996 Jan;52(1):27-31. doi: 10.1016/S0377-1237(17)30830-4. Epub 2017 Jun 26.
2
A clinico-pathologic study of pituitary adenomas.
Indian J Med Res. 1990 Oct;92:315-23.
3
[Immunohistochemical and ultrastructural study of plurihormonal pituitary adenomas].多激素垂体腺瘤的免疫组织化学和超微结构研究
Zhonghua Yi Xue Za Zhi. 1993 Apr;73(4):223-5, 254.
4
Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.嗜酸细胞系多激素垂体腺瘤的体外激素分泌
J Clin Endocrinol Metab. 1992 Jul;75(1):68-75. doi: 10.1210/jcem.75.1.1352308.
5
Plurihormonality of pituitary adenomas in light of immunohistochemical studies.根据免疫组织化学研究,垂体腺瘤的多激素性。
Endokrynol Pol. 2010 Jan-Feb;61(1):63-6.
6
Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.尸检垂体中的亚临床腺瘤:分类及其与临床数据的相关性
Eur J Endocrinol. 2006 May;154(5):753-8. doi: 10.1530/eje.1.02107.
7
Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.多激素垂体腺瘤:对所有垂体激素进行免疫染色对于正确分类至关重要。
Histopathology. 2001 Sep;39(3):310-9. doi: 10.1046/j.1365-2559.2001.01204.x.
8
Current pathological classification of pituitary adenomas.垂体腺瘤的当前病理分类。
Acta Neurochir Suppl. 1996;65:1-3. doi: 10.1007/978-3-7091-9450-8_1.
9
An overview of pituitary tumors.垂体肿瘤概述。
Ann Clin Lab Sci. 1979 Mar-Apr;9(2):94-102.
10
[Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].生长激素分泌型垂体腺瘤中垂体激素及Ki-67的免疫组织化学研究
Rev Med Chil. 2008 Jul;136(7):831-6. Epub 2008 Sep 4.

本文引用的文献

1
The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.免疫组织化学的未标记抗体酶法:可溶性抗原-抗体复合物(辣根过氧化物酶-抗辣根过氧化物酶)的制备、性质及其在螺旋体鉴定中的应用
J Histochem Cytochem. 1970 May;18(5):315-33. doi: 10.1177/18.5.315.
2
Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.垂体的乳腺生长激素细胞腺瘤伴巨人症和高催乳素血症。一项包括免疫电子显微镜检查的形态学研究。
Acta Neuropathol. 1986;71(1-2):76-82. doi: 10.1007/BF00687965.
3
Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.混合分泌生长激素(GH)和催乳素(PRL)的人垂体腺瘤的形态学研究。GH和PRL在同一分泌颗粒中共存。
J Clin Endocrinol Metab. 1986 Jun;62(6):1093-100. doi: 10.1210/jcem-62-6-1093.
4
A clinico-pathologic study of pituitary adenomas.
Indian J Med Res. 1990 Oct;92:315-23.
5
Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age.
J Neurosurg. 1991 Dec;75(6):902-5. doi: 10.3171/jns.1991.75.6.0902.
6
Ultrastructural classification of pituitary adenomas.垂体腺瘤的超微结构分类
Can J Neurol Sci. 1976 Feb;3(1):9-21. doi: 10.1017/s0317167100025944.

垂体腺瘤研究中的激素标志物

HORMONAL MARKERS IN THE STUDY OF PITUITARY ADENOMAS.

作者信息

Bhardwaj J R, Somanathan T, Kumar Harsh, Sivadas P, Reddy P S

机构信息

Senior Adviser (Pathology), Army Hospital, Delhi Cantt.

Post Graduate, Dept of Pathology, Armed Forces Medical College, Pune.

出版信息

Med J Armed Forces India. 1996 Jan;52(1):27-31. doi: 10.1016/S0377-1237(17)30830-4. Epub 2017 Jun 26.

DOI:10.1016/S0377-1237(17)30830-4
PMID:28769332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5530270/
Abstract

Twenty pituitary adenomas were studied using light microscopy, immunohistochemistry and electron microscopy. Based on clinical manifestations of hormonal hypersecretion they were divided into two groups, i.e. group-I (12 patients) with no endocrine dysfunction and group-II (8 patients) with endocrine dysfunction. Group-I could be further sub-divided into two groups based on IHC : group LA in which no hormone could be localised in the tissue (null cell adenomas) and group IB where hormones could be localised in the tissue (1). Tumours in group II, with light microscopy, were acidophil (n=5), basophil (n=1) or mixed (n=2) adenomas. Eight of these 20 cases were plurihormonal. Growth hormone, and prolactin were the commonest combination. This study has helped in the reclassification of the pituitary adenomas according to the hormone they produce.

摘要

采用光学显微镜、免疫组织化学和电子显微镜对20例垂体腺瘤进行了研究。根据激素分泌过多的临床表现,将它们分为两组,即无内分泌功能障碍的I组(12例患者)和有内分泌功能障碍的II组(8例患者)。I组根据免疫组织化学可进一步细分为两组:LA组,组织中未发现激素(无功能性腺瘤);IB组,组织中可发现激素(1例)。II组肿瘤,光学显微镜下观察,为嗜酸细胞瘤(n = 5)、嗜碱细胞瘤(n = 1)或混合性腺瘤(n = 2)。这20例中有8例为多激素型。生长激素和催乳素是最常见的组合。这项研究有助于根据垂体腺瘤所产生的激素对其进行重新分类。